Differential effects of angiotensin II type I receptor blockers on reducing intraocular pressure and TGFβ signaling in the mouse retina.
PURPOSE:Angiotensin II type 1 receptor blockers (ARBs) have been investigated for their neuroprotective and intraocular pressure (IOP) lowering effects in treating glaucoma, but the reports have been inconsistent possibly because different compounds and models have been used. Here we selected three...
Main Authors: | Ralph J Hazlewood, Qingxia Chen, Frances K Clark, John Kuchtey, Rachel W Kuchtey |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6084929?pdf=render |
Similar Items
-
Not too long, not too short: Goldilocks principle of eye size.
by: Rachel W Kuchtey
Published: (2020-07-01) -
Effect of β-blockers and carbonic anhydrase inhibitors on postoperative intraocular pressure control of neovascular glaucoma
by: Chao-Hai Ni, et al.
Published: (2016-03-01) -
TGFβ-Neurotrophin Interactions in Heart, Retina, and Brain
by: Anja Schlecht, et al.
Published: (2021-09-01) -
The effect of oxidative stress on intraocular pressure and retina in rats
by: Chia-Ling Pai, et al.
Published: (2014) -
Long-term intraocular pressure after switching a combination ophthalmic medication of β-blocker/prostaglandin
by: Yukihisa Takada, et al.
Published: (2020-01-01)